Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ECTRIMS 2021 | The importance of assessing autoreactive T-cell responses in MS

Olivia Thomas, PhD, Karolinska Institute, Solna, Sweden, talks on the importance of characterizing autoreactive T-cell responses in patients with multiple sclerosis (MS). Dr Thomas emphasizes the heterogeneous nature of MS, with patients showing substantial variability in disease course, treatment responses, and clinical symptoms. It is therefore important that MS therapy becomes more tailored to each individual patient. Dr Thomas notes how characterization of individual autoreactive T-cell responses may help achieve this. This interview took place at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress 2021.

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.